Which of the following is a disadvantage of PCSK9 inhibitor?
A) Annual cost of $15,000 a year
B) Reduction in the number of apheresis treatment
C) Significant reduction in LDL (50-75%) on top of statin therapy
D) Biweekly or monthly administration
Correct Answer:
Verified
Q25: The maximum dose of Niaspan ER is:
A)
Q26: The following drug(s) is/are available over the
Q27: How should you counsel a patient to
Q28: In the setting of acute coronary syndrome,
Q29: The generic name for Mevacor is:
A) Simvastatin
B)
Q31: Fluvastatin is metabolized by the _ system.
A)
Q32: What is the mechanism of action of
Q33: Which of the following is true regarding
Q34: Essential monitoring parameters for statins include all
Q35: All of the following drugs require renal
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents